Electronic Health Records - Charting the Future of Health Care -





Published: January 2013 | Pages: 53 | Format: PDF

 Electronic Health Records have been in limited use since the 1960s, but their adoption received a major boost when they became more of a focus for the US government. In 2004, President Bush put forth the goal of having every American covered by an EHR within 10 years. In 2009, President Obama added the key element of funding under the American Recovery and Reinvestment Act. The EHR Meaningful Use Incentive programs funded under the ARA were further bolstered by programs in the 2010 health care reform legislation which promoted Accountable Care Organizations. 

 After the results of the November elections and the Supreme Court’s ruling upholding the individual mandate, the future for health care reform would look more sure. However, recently some Republican members of congress have turned their attention to EHR programs, questioning whether they are an effective use of funding. 

 The report, “Electronic Health Records - Charting the Future of Health Care”, was designed to provide insights and analysis on a topic that is being felt from government agencies to treating physicians, while also impacting the pharmaceutical industry. CBR Pharma Insights not only provides in-depth analysis on the technology being used, the adoption of this technology, and the trends being seen locally and globally, but also how EHRs could impact pharmaceutical companies. 

 Key Reasons to Purchase 

 

  •  Understand and evaluate the criticisms behind the use of Electronic Health Records 
  •  Analyze the challenges facing Electronic Health Records adoption 
  •  Understand the role government has played in the development of Electronic Health Records in the US and the debates that are currently taking place over their use 
  •  Gain insights around the attempts being made to develop Electronic Health Records systems throughout the world, where they are showing positive signs of success, and where more work needs to be done 
  •  Assess the potential benefits of the use of Electronic Health Records for the pharmaceutical industry and the opportunities that exist for your company 

 

 Executive Summary 

 Chapter 1: Development of Electronic Health Records 

 

  •  Definition 
  •  Early use 
  •  Pre-reform programs 
  •  2010 Health Care reform programs for EHRs 
  •  Meaningful Use incentive programs 
  •  Post-election direction for EHRs  

 

 Chapter 2: Technology 

 

  •  EHR systems 
  •  Mobile technology 
  •  HIPAA and privacy  

 

 Chapter 3: Adoption of EHRs 

 

  •  Adoption rates 
  •  Physician opinions 
  •  Impact on the physician-patient relationship 
  •  Implementation challenges  

 

 Chapter 4: Impact of EHR use 

 

  •  Case study: Diabetes 
  •  Case study: Diagnostic imaging 
  •  Case study: preventative care 
  •  Case study: drug safety  

 

 Chapter 5: EHR use outside of the US 

 

  •  Canada 
  •  Europe 
  •  Asia 
  •  Emerging markets 
  •  Lessons of implementation  

 

 Chapter 6: The outlook for EHRs 

 

  •  Politics 
  •  Billing 
  •  Cloning 
  •  The CBR View  

 

 Appendix